Founders’ Circle
Partnerships with donors make discoveries possible. Thank you to those who have committed $500,000 or more to The Patrick C. Walsh Prostate Cancer Research Fund.
A Publication of the Patrick C. Walsh Prostate Cancer Research Fund
Winter 2023
-
-
A Message from our Director
-
After 45 Years at the Brady, John Isaacs Retires
-
Newly Discovered Mutation on HOXB13 is Linked to More Aggressive Cancer in Black Men
-
GSTP1: Could This Gene Be Linked to Cancer Death in Black Men?
-
Prostate Cancer Genetic Risk Score in Black Men
-
Precision Medicine: Genetics and Clinical Outcomes in Advanced Prostate Cancer
-
Schaufeld Program Celebrates First Year
-
Micro-Ultrasound: A New Approach to Prostate Biopsy
-
Turning Back the Clock on Treatment-Resistant Prostate Cancer
-
Prostate Cancer in Transgender Patients
-
Low-Intensity Electrostimulation May Improve Erectile Recovery
-
Recent Brady Honors & Awards
-
A Beautiful Friendship, and a Remarkable Gift
-
Neoadjuvant Therapy and High-Risk Localized Prostate Cancer
-
Gleason 3+3=6 is Not “Not Cancer”
-
Finding Metastatic Prostate Cancer that Doesn’t Make PSMA
-
Gut Bugs and Treatment Response in Metastatic Prostate Cancer
-
Therapy Resistance in Cancer: Learning from Bacteria
-
Embryonic Genes Reactivated in Advanced Prostate Cancer
-
For Prostate Cancer Patients with Mismatch Repair Deficiency, Immunotherapy Alone?
-
Read About the Research You Have Helped Make Possible.
-
Kidney Cancer Program: World-Class Care and Research
-
Kidney Cancer and Brain Metastases
-
Is There a PSMA for Kidney Cancer?
-
Exercise, Immunotherapy, and Metastatic Kidney Cancer
-
Managing a Tumor Thrombus in Kidney Cancer
-
Testicular Cancer in Children
-
A Novel Study for Patients with Small Cell Bladder Cancer
-
DNA Damage-Repair Gene Mutations and Neoadjuvant Chemotherapy in MIBC
-
Neoadjuvant Chemotherapy and Surgery for MIBC: What’s a Successful Response?
-
Race, Ethnicity and Clinical Trials